{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:21:22Z","timestamp":1790979682586,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaci.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T03:33:35Z","timestamp":1524713615000},"page":"1831-1842.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Stefanie","family":"Haeberle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Goletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Enk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva N.","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.04.006_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1346-8138.2009.00797.x","article-title":"Immune dysregulation of pemphigus in humans and mice","volume":"37","author":"Yokoyama","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.04.006_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2018.04.006_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/1523-1747.ep12343081","article-title":"Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients","volume":"106","author":"Amagai","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2018.04.006_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000131453","article-title":"Pemphigus vulgaris and its active disease mouse model","volume":"10","author":"Amagai","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.jaci.2018.04.006_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib17","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.0022-202X.2005.23702.x","article-title":"Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita","volume":"124","author":"Woodley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/exd.12011","article-title":"Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models","volume":"21","author":"Ujiie","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib20","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T\u00a0cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2567.2008.02932.x","article-title":"Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3","volume":"127","author":"Veldman","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2018.04.006_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clim.2011.10.002","article-title":"Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","volume":"142","author":"Ujiie","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib23","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4049\/jimmunol.1300310","article-title":"B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita","volume":"191","author":"Iwata","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2018.04.006_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.04.006_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.04.006_bib29","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/jid.2010.16","article-title":"Autoantibodies in scurfy mice and IPEX patients recognize keratin 14","volume":"130","author":"Huter","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib30","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.4049\/jimmunol.153.8.3764","article-title":"CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse","volume":"153","author":"Blair","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-015-0538-0","article-title":"Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease","volume":"17","author":"Hadaschik","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2018.04.006_bib32","doi-asserted-by":"crossref","first-page":"19042","DOI":"10.1073\/pnas.1313547110","article-title":"B cells are critical for autoimmune pathology in Scurfy mice","volume":"110","author":"Aschermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.04.006_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.04.006_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.04.006_bib35","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1101328","article-title":"Regulation of the germinal center reaction by Foxp3+ follicular regulatory T\u00a0cells","volume":"187","author":"Wollenberg","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0205s74","article-title":"Production of monoclonal antibodies","author":"Yokoyama","year":"2006","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib37","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/eji.200838346","article-title":"TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice","volume":"38","author":"Huter","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2011.04.071","article-title":"Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR","volume":"585","author":"Leineweber","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2018.04.006_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib40","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves c5ar1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib42","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","article-title":"Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice","volume":"187","author":"Hirose","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib43","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1073\/pnas.0809230106","article-title":"Anti-laminin gamma-1 pemphigoid","volume":"106","author":"Dainichi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.04.006_bib44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.04.006_bib45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in\u00a0vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib46","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12358276","article-title":"Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid","volume":"101","author":"Hall","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.humimm.2014.01.005","article-title":"IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice","volume":"75","author":"Feldrihan","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2018.04.006_bib51","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2174\/1381612033454379","article-title":"Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications","volume":"9","author":"Ruiz-Arguelles","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaci.2018.04.006_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/jaut.1998.0217","article-title":"Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications","volume":"11","author":"Madaio","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2018.04.006_bib53","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00018-009-9179-2","article-title":"A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity","volume":"66","author":"Jang","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2018.04.006_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(95)90333-X","article-title":"Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration","volume":"81","author":"Guo","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2018.04.006_bib55","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/labinvest.2016.108","article-title":"Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C","volume":"96","author":"Iwata","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib56","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib57","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1684\/ejd.2014.2369","article-title":"Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions","volume":"24","author":"Hara","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib59","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib60","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.0803762","article-title":"Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice","volume":"183","author":"Lahl","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib61","first-page":"282","article-title":"Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2","volume":"110","author":"Haase","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib63","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","article-title":"Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice","volume":"187","author":"Hirose","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.04.006_bib64","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2011.04.071","article-title":"Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR","volume":"585","author":"Leineweber","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2018.04.006_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.04.006_bib66","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves c5ar1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.04.006_bib67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:16:36Z","timestamp":1758791796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918306146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0091674918306146"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.04.006","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733126252.793548540","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}